HZI cpi leute 01

Molecular Bacteriology

Hospital germs are a huge problem - despite controlled hygiene numerous patients capture so-called hospital acquired infections in addition to their actual disease. In many cases the pathogens are resistant to antibiotics and, therefore, very difficult to combat. Read more about how bacteria join forces and what the researchers can do to avoid that. The group Molecular Bacteriology is based at the TWINCORE in Hannover.



  1. Transcriptome profiling of antimicrobial resistance in Pseudomonas aeruginosa. Khaledi A, Schniederjans M, Pohl S, Rainer R, Bodenhofer U, Xia B, Klawonn F, Bruchmann S, Preusse M, Eckweiler D, Dötsch A, Häussler S. Antimicrob Agents Chemother. 2016 May 23. pii: AAC.00075-16. [Epub ahead of print]
  2. Functional modules of sigma factor regulons guarantee adaptability and evolvability. Binder SC, Eckweiler D, Schulz S, Bielecka A, Nicolai T, Franke R, Häussler S, Meyer-Hermann M. Sci Rep. 2016 Feb 26;6:22212. doi: 10.1038/srep22212.RNASeq Based Transcriptional Profiling of Pseudomonas aeruginosa PA14 after Short- and Long-Term Anoxic Cultivation in Synthetic Cystic Fibrosis Sputum Medium. Tata M, Wolfinger MT, Amman F, Roschanski N, Dötsch A, Sonnleitner E, Häussler S, Bläsi U.PLoS One. 2016 Jan 28;11(1):e0147811. doi: 10.1371/journal.pone.0147811. eCollection 2016.
  3. The LasB Elastase of Pseudomonas aeruginosa Acts in Concert with Alkaline Protease AprA To Prevent Flagellin-Mediated Immune Recognition. Casilag F, Lorenz A, Krueger J, Klawonn F, Weiss S, Häussler S. Infect Immun. 2015 Oct 26;84(1):162-71. doi: 10.1128/IAI.00939-15.
  4. Application of Synthetic Peptide Arrays To Uncover Cyclic Di-GMP Binding Motifs. Düvel J, Bense S, Möller S, Bertinetti D, Schwede F, Morr M, Eckweiler D, Genieser HG, Jänsch L, Herberg FW, Frank R, Häussler S. J Bacteriol. 2015 Aug 31;198(1):138-46. doi: 10.1128/JB.00377-15.
  5. Deep transcriptome profiling of clinical Klebsiella pneumoniae isolates reveals strain and sequence type-specific adaptation. Bruchmann S, Muthukumarasamy U, Pohl S, Preusse M, Bielecka A, Nicolai T, Hamann I, Hillert R, Kola A, Gastmeier P, Eckweiler D, Häussler S. Environ Microbiol. 2015 Nov;17(11):4690-710. doi: 10.1111/1462-2920.13016. Epub 2015 Sep 10.
  6. The Pseudomonas aeruginosa Transcriptional Landscape Is Shaped by Environmental Heterogeneity and Genetic Variation. Dötsch A, Schniederjans M, Khaledi A, Hornischer K, Schulz S, Bielecka A, Eckweiler D, Pohl S, Häussler S. MBio. 2015 Jun 30;6(4):e00749. doi: 10.1128/mBio.00749-15.
  7. Cross talk between the response regulators PhoB and TctD allows for the integration of diverse environmental signals in Pseudomonas aeruginosa. Bielecki P, Jensen V, Schulze W, Gödeke J, Strehmel J, Eckweiler D, Nicolai T, Bielecka A, Wille T, Gerlach RG, Häussler S. Nucleic Acids Res. 2015 Jul 27;43(13):6413-25. doi: 10.1093/nar/gkv599. Epub 2015 Jun 16.
  8. In Vivo Efficacy of Antimicrobials against Biofilm-Producing Pseudomonas aeruginosa. Pawar V, Komor U, Kasnitz N, Bielecki P, Pils MC, Gocht B, Moter A, Rohde M, Weiss S, Häussler S. Antimicrob Agents Chemother. 2015 Aug;59(8):4974-81. doi: 10.1128/AAC.00194-15. Epub 2015 Jun 8.
  9. Constitutive production of c-di-GMP is associated with mutations in a variant of Pseudomonas aeruginosa with altered membrane composition. Blanka A, Düvel J, Dötsch A, Klinkert B, Abraham WR, Kaever V, Ritter C, Narberhaus F, Häussler S. Sci Signal. 2015 Apr 14;8(372):ra36. doi: 10.1126/scisignal.2005943.
  10. Corrigendum: Arginine-rhamnosylation as new strategy to activate translation elongation factor P. Lassak J, Keilhauer EC, Fürst M, Wuichet K, Gödeke J, Starosta AL, Chen JM, Søgaard-Andersen L, Rohr J, Wilson DN, Häussler S, Mann M, Jung K. Nat Chem Biol. 2015 Apr;11(4):299. doi: 10.1038/nchembio0415-299d. No abstract available. 
  11. Elucidation of sigma factor-associated networks in Pseudomonas aeruginosa reveals a modular architecture with limited and function-specific crosstalk. Schulz S, Eckweiler D, Bielecka A, Nicolai T, Franke R, Dötsch A, Hornischer K, Bruchmann S, Düvel J, Häussler S. PLoS Pathog. 2015 Mar 17;11(3):e1004744. doi: 10.1371/journal.ppat.1004744. eCollection 2015 Mar.
  12. Arginine-rhamnosylation as new strategy to activate translation elongation factor P. Lassak J, Keilhauer EC, Fürst M, Wuichet K, Gödeke J, Starosta AL, Chen JM, Søgaard-Andersen L, Rohr J, Wilson DN, Häussler S, Mann M, Jung K. Nat Chem Biol. 2015 Apr;11(4):266-70. doi: 10.1038/nchembio.1751. Epub 2015 Feb 16. Erratum in: Nat Chem Biol. 2015 Apr;11(4):299. 
  13. Contribution of Veillonella parvula to Pseudomonas aeruginosa-mediated pathogenicity in a murine tumor model system. Pustelny C, Komor U, Pawar V, Lorenz A, Bielecka A, Moter A, Gocht B, Eckweiler D, Müsken M, Grothe C, Lünsdorf H, Weiss S, Häussler S. Infect Immun. 2015 Jan;83(1):417-29. doi: 10.1128/IAI.02234-14. Epub 2014 Nov 10.
  14. Pseudomonas aeruginosa LysR PA4203 regulator NmoR acts as a repressor of the PA4202 nmoA gene, encoding a nitronate monooxygenase. Vercammen K, Wei Q, Charlier D, Dötsch A, Häussler S, Schulz S, Salvi F, Gadda G, Spain J, Rybtke ML, Tolker-Nielsen T, Dingemans J, Ye L, Cornelis P. J Bacteriol. 2015 Mar;197(6):1026-39. doi: 10.1128/JB.01991-14. Epub 2014 Nov 10.
  15. The PqsR and RhlR transcriptional regulators determine the level of Pseudomonas quinolone signal synthesis in Pseudomonas aeruginosa by producing two different pqsABCDE mRNA isoforms. Brouwer S, Pustelny C, Ritter C, Klinkert B, Narberhaus F, Häussler S. J Bacteriol. 2014 Dec;196(23):4163-71. doi: 10.1128/JB.02000-14. Epub 2014 Sep 15.
  16. In vivo mRNA profiling of uropathogenic Escherichia coli from diverse phylogroups reveals common and group-specific gene expression profiles. Bielecki P, Muthukumarasamy U, Eckweiler D, Bielecka A, Pohl S, Schanz A, Niemeyer U, Oumeraci T, von Neuhoff N, Ghigo JM, Häussler S. MBio. 2014 Aug 5;5(4):e01075-14. doi: 10.1128/mBio.01075-14.
  17. Extensively drug-resistant pseudomonas aeruginosa isolates containing blaVIM-2 and elements of Salmonella genomic island 2: a new genetic resistance determinant in Northeast Ohio. Perez F, Hujer AM, Marshall SH, Ray AJ, Rather PN, Suwantarat N, Dumford D 3rd, O'Shea P, Domitrovic TN, Salata RA, Chavda KD, Chen L, Kreiswirth BN, Vila AJ, Haussler S, Jacobs MR, Bonomo RA. Antimicrob Agents Chemother. 2014 Oct;58(10):5929-35. doi: 10.1128/AAC.02372-14. Epub 2014 Jul 28.
  18. Production of medium chain length polyhydroxyalkanoate in metabolic flux optimized Pseudomonas putida. Borrero-de Acuña JM, Bielecka A, Häussler S, Schobert M, Jahn M, Wittmann C, Jahn D, Poblete-Castro I. Microb Cell Fact. 2014 Jun 19;13:88. doi: 10.1186/1475-2859-13-88.
  19. Chromatin immunoprecipitation for ChIP-chip and ChIP-seq. Schulz S, Häussler S. Methods Mol Biol. 2014;1149:591-605. doi: 10.1007/978-1-4939-0473-0_45.
  20. The extensive set of accessory Pseudomonas aeruginosa genomic components. Pohl S, Klockgether J, Eckweiler D, Khaledi A, Schniederjans M, Chouvarine P, Tümmler B, Häussler S. FEMS Microbiol Lett. 2014 Jul;356(2):235-41. doi: 10.1111/1574-6968.12445. Epub 2014 May 12.
  21. Neutrophil elastase-mediated increase in airway temperature during inflammation. Schmidt A, Belaaouaj A, Bissinger R, Koller G, Malleret L, D'Orazio C, Facchinelli M, Schulte-Hubbert B, Molinaro A, Holst O, Hammermann J, Schniederjans M, Meyer KC, Damkiaer S, Piacentini G, Assael B, Bruce K, Häußler S, LiPuma JJ, Seelig J, Worlitzsch D, Döring G. J Cyst Fibros. 2014 Dec;13(6):623-31. doi: 10.1016/j.jcf.2014.03.004. Epub 2014 Apr 6.
  22. Effects of green tea compound epigallocatechin-3-gallate against Stenotrophomonas maltophilia infection and biofilm. Vidigal PG, Müsken M, Becker KA, Häussler S, Wingender J, Steinmann E, Kehrmann J, Gulbins E, Buer J, Rath PM, Steinmann J. PLoS One. 2014 Apr 1;9(4):e92876. doi: 10.1371/journal.pone.0092876. eCollection 2014.
  23. IL-17-induced CXCL12 recruits B cells and induces follicle formation in BALT in the absence of differentiated FDCs. Fleige H, Ravens S, Moschovakis GL, Bölter J, Willenzon S, Sutter G, Häussler S, Kalinke U, Prinz I, Förster R. 
  24. Pseudomonas aeruginosa ceftolozane-tazobactam resistance development requires multiple mutations leading to overexpression and structural modification of AmpC. Cabot G, Bruchmann S, Mulet X, Zamorano L, Moyà B, Juan C, Haussler S, Oliver A. Antimicrob Agents Chemother. 2014 Jun;58(6):3091-9. doi: 10.1128/AAC.02462-13. Epub 2014
  25. Complete Genome Sequence of Highly Adherent Pseudomonas aeruginosa Small-Colony Variant SCV20265. Eckweiler D, Bunk B, Spröer C, Overmann J, Häussler S. Genome Announc. 2014 Jan 23;2(1). pii: e01232-13. doi: 10.1128/genomeA.01232-13.
  26. Identification of the alternative sigma factor SigX regulon and its implications for Pseudomonas aeruginosa pathogenicity. Blanka A, Schulz S, Eckweiler D, Franke R, Bielecka A, Nicolai T, Casilag F, Düvel J, Abraham WR, Kaever V, Häussler S. J Bacteriol. 2014 Jan;196(2):345-56. doi: 10.1128/JB.01034-13. Epub 2013 Nov 1.
  27. Haussler S, Fuqua C. Biofilms 2012: new discoveries and significant wrinkles in a dynamic field. J Bacteriol. (2013) Jul;195(13):2947-58 IF: 3,59
  28. Gödeke J, Pustelny C, Häussler SRecycling of peptidyl-tRNAs by peptidyl-tRNA hydrolase counteracts azithromycin-mediated effects on Pseudomonas aeruginosa. Antimicrob Agents Chemother. (2013) Apr;57(4):1617-24. IF: 4,60
  29. Pustelny C, Brouwer S, Müsken M, Bielecka A, Dötsch A, Nimtz M, Häussler SThe peptide chain release factor methyltransferase PrmC is essential for pathogenicity and environmental adaptation of Pseudomonas aeruginosa PA14. Environ Microbiol. (2013) Feb;15(2):597-609 IF: 5,94
  30. Bruchmann S, Dötsch A, Nouri B, Chaberny IF, Häussler SQuantitative contributions of target alteration and decreased drug accumulation to Pseudomonas aeruginosa fluoroquinolone resistance. Antimicrob Agents Chemother.( 2013) Mar;57(3):1361-8. IF: 4,60
  31. Bielecki P, Komor U, Bielecka A, Müsken M, Puchałka J, Pletz MW, Ballmann M, Martins dos Santos VA, Weiss S, Häussler SEx vivo transcriptional profiling reveals a common set of genes important for the adaptation of Pseudomonas aeruginosa to chronically infected host sites. Environ Microbiol. (2013) Feb;15(2):570-87. IF: 5,94
  32. Bielecki P, Lukat P, Hüsecken K, Dötsch A, Steinmetz H, Hartmann RW, Müller R, Häussler SMutation in elongation factor G confers resistance to the antibiotic argyrin in the opportunistic pathogen Pseudomonas aeruginosa. Chembiochem. (2012) Nov 5;13(16):2339-45. IF: 3,67
  33. Storz MP, Maurer CK, Zimmer C, Wagner N, Brengel C, de Jong JC, Lucas S, Müsken M, Häussler S, Steinbach A, Hartmann RW. Validation of PqsD as an anti-biofilm target in Pseudomonas aeruginosa by development of small-molecule inhibitors.  J Am Chem Soc.(2012) Oct 3;134(39):16143-6. IF: 10,24
  34. Malone JG, Jaeger T, Manfredi P, Dötsch A, Blanka A, Bos R, Cornelis GR, Häussler S, Jenal U. The YfiBNR signal transduction mechanism reveals novel targets for the evolution of persistent Pseudomonas aeruginosa in cystic fibrosis airways. PLoS Pathog. (2012);8(6):e1002760.  IF: 8,92
  35. Komor U, Bielecki P, Loessner H, Rohde M, Wolf K, Westphal K, Weiss S, Häussler SBiofilm formation by Pseudomonas aeruginosa in solid murine tumors - a novel model system. Microbes Infect. (2012) Sep;14(11):951-8. IF: 2,82
  36. Lu C, Kirsch B, Zimmer C, de Jong JC, Henn C, Maurer CK, Müsken M, Häussler S, Steinbach A, Hartmann RW. Discovery of antagonists of PqsR, a key player in 2-alkyl-4-quinolone-dependent quorum sensing in Pseudomonas aeruginosa. Chem Biol. (2012) Mar 23;19(3):381-90. IF: 6,10
  37. Selezska K, Kazmierczak M, Müsken M, Garbe J, Schobert M, Häussler S, Wiehlmann L, Rohde C, Sikorski J. Pseudomonas aeruginosa population structure revisited under environmental focus: impact of water quality and phage pressure. Environ Microbiol.( 2012) Aug;14(8):1952-67. IF: 5,94
  38. Dötsch A, Eckweiler D, Schniederjans M, Zimmermann A, Jensen V, Scharfe M, Geffers R, Häussler SThe Pseudomonas aeruginosa transcriptome in planktonic cultures and static biofilms using RNA sequencing. PLoS One. (2012);7(2):e31092 IF: 4,24
  39. Wei Q, Minh PN, Dötsch A, Hildebrand F, Panmanee W, Elfarash A, Schulz S, Plaisance S, Charlier D, Hassett D, Häussler S, Cornelis P. Global regulation of gene expression by OxyR in an important human opportunistic pathogen. Nucleic Acids Res. (2012) May;40(10):4320-33. IF: 8,06
  40. Wei Q, Tarighi S, Dötsch A, Häussler S, Müsken M, Wright VJ, Cámara M, Williams P, Haenen S, Boerjan B, Bogaerts A, Vierstraete E, Verleyen P, Schoofs L, Willaert R, De Groote VN, Michiels J, Vercammen K, Crabbé A, Cornelis P. Phenotypic and genome-wide analysis of an antibiotic-resistant small colony variant (SCV) of Pseudomonas aeruginosa. PLoS One. (2011);6(12):e29276. IF: 4,24
  41. Düvel J, Bertinetti D, Möller S, Schwede F, Morr M, Wissing J, Radamm L, Zimmermann B, Genieser HG, Jänsch L, Herberg FW, Häussler SA chemical proteomics approach to identify c-di-GMP binding proteins in Pseudomonas aeruginosa. J Microbiol Methods. (2012) Feb;88(2):229-36. IF: 2,51
  42. Zaoui C, Overhage J, Löns D, Zimmermann A, Müsken M, Bielecki P, Pustelny C, Becker T, Nimtz M, Häussler SAn orphan sensor kinase controls quinolone signal production via MexT in Pseudomonas aeruginosa. Mol Microbiol. (2012) Feb;83(3):536-47. IF: 5,10
  43. Schmidt J, Müsken M, Becker T, Magnowska Z, Bertinetti D, Möller S, Zimmermann B, Herberg FW, Jänsch L, Häussler S. (2011) The Pseudomonas aeruginosa chemotaxis methyltransferase CheR1 impacts on bacterial surface ampling. PLoS One. 2011 Mar 22;6(3):e18 IF: 4.41
  44. Müsken M, DiFiore S, Dötsch A, Fischer R, Häussler S (2010) Genetic determinants of Pseudomonas aeruginosa biofilm establishment. Microbiology. 156:431-41. IF: 2.96
  45. Müsken M, DiFiore S, Römling U, Häussler S. (2010) 96-well plate based optical method for the quantitative and qualitative evaluation of Pseudomonas aeruginosa biofilm formation and its application for susceptibility testing. Nat Protoc. 5:1460-9. IF 8.36
  46. PommerenkeC, Müsken M, Becker T, Dötsch A, Overhage J, Klawonn F, Häussler S. (2010) Global Phenotype-Genotype correlations in Pseudomonas aeruginosa PLoS Pathog. 26(3): pii: e1001074. IF: 9.07
  47. Dötsch A, Klawonn F, Jarek M, Scharfe M, Blöcker H, Häussler S. (2010) Evolutionary conservation of essential and highly expressed genes in Pseudomonas aeruginosa. BMC Genomics. 9(11):234. IF: 4.21
  48. Bohn YS, Brandes G, Rakhimova E, Horatzek S, Salunkhe P, Munder A, van Barneveld A, Jordan D, Bredenbruch F, Häussler S, Riedel K, Eberl L, Jensen PO, Bjarnsholt T, Moser C, Hoiby N, Tummler B, Wiehlmann L (2009) Multiple roles of Pseudomonas aeruginosa TBCF10839 PilY1 in motility, transport and infectionMol Microbiol 71(3): 730-747 IF: 4.82
  49. Dotsch A, Becker T, Pommerenke C, Magnowska Z, Jansch L, Häussler S (2009) Genome-wide identification of genetic determinants of antimicrobial drug resistance in Pseudomonas aeruginosaAntimicrob Agents Chemother 53(6): 2522-2531. IF: 4.67
  50. Dotsch A, Pommerenke C, Bredenbruch F, Geffers R, Häussler S (2009) Evaluation of a microarray-hybridization based method applicable for discovery of single nucleotide polymorphisms (SNPs) in the Pseudomonas aeruginosa genome. BMC Genomics 10: 29 IF: 4.21
  51. Moya B, Dotsch A, Juan C, Blazquez J, Zamorano L, Häussler S, Oliver A (2009) Beta-lactam resistance response triggered by inactivation of a nonessential penicillin-binding proteinPLoS Pathog 5(3): e1000353 IF: 9.07
  52. Yu S, Jensen V, Seeliger J, Feldmann I, Weber S, Schleicher E, Häussler S, Blankenfeldt W (2009) Structure Elucidation and Preliminary Assessment of Hydrolase Activity of PqsE, the Pseudomonas Quinolone Signal (PQS) Response Protein. Biochemistry (2009)48(43):10298-10307. IF: 3.23
  53. Haddad A, Jensen V, Becker T, Häussler S (2009) The Pho regulon influences biofilm formation and type three secretion in Pseudomonas aeruginosa. Environmental Microbiology reports 6: 488- 494.
  54. Häussler S. and Becker T. (2008) The pseudomonas quinolone signal (PQS) balances life and death in Pseudomonas aeruginosa populations. PLoS Pathogens 26;4:e1000166. IF 9.07
  55. Balke,B., Schmoldt,S., Häussler,S., Suerbaum,S., Heesemann,J., and Hogardt,M. A German external quality survey of diagnostic microbiology of respiratory tract infections in patients with cystic fibrosis. J Cyst Fibros. 7 :7-14. (2008) IF: 2.84
  56. Meissner, A, V. Wild, R. Simm, M. Rohde, C. Erck, F. Bredenbruch, M. Morr, U. Römling, S. HäusslerPseudomonas aeruginosa cupA encoded fimbriae expression is regulated by a GGDEF and EAL domain dependent modulation of the intracellular level of cyclic diguanylate. Environ Microbiol. 9:2475-85. (2007) IF: 5.54
  57. Jensen, V, D. Löns, C. Zaoui, F. Bredenbruch, A. Meissner, G. Dieterich, R. Münch and S. Häussler. RhlR Expression in Pseudomonas aeruginosa Is Modulated by the Pseudomonas Quinolone Signal via PhoB-Dependent and -Independent Pathways. J Bacteriol.;188:8601-6. (2006) IF: 3.73
  58. Bredenbruch, F, R. Geffers, M. Nimtz, J. Buer and S. Häussler. The Pseudomonas aeruginosa quinolone signal (PQS) has an iron-chelating activity. Environ Microbiol. 8:1318-29. (2006) IF: 5.54
  59. Vonberg, RP, S. Häussler, P. Vandamme and I. Steinmetz. Identification of Burkholderia cepacia complex pathogens by rapid-cycle PCR with fluorescent hybridization probes. J Med Microbiol. 55:721-7. (2006) IF: 2.38
  60. Romero-Tabarez, M, R. Jansen, M. Sylla, H. Lünsdorf, S. Häussler, D.A. Santosa, K.N. Timmis and G. Molinari. 7-O-malonyl macrolactin A, a new macrolactin antibiotic from Bacillus subtilis active against methicillin-resistant Staphylococcus aureus, vancomycin-resistant enterococci, and a small-colony variant of Burkholderia cepacia. Antimicrob Agents Chemother. 50:1701-9. (2006) IF: 4.67
  61. Nalca, Y, L. Jänsch, F. Bredenbruch,.R. Geffers, J. Buer and S. Häussler. Quorum-sensing antagonistic activities of azithromycin in Pseudomonas aeruginosa PAO1: a global approach. Antimicrob Agents Chemother.50:1680-8. (2006) IF: 4.67
  62. Balke, B, M. Hogardt, S. Schmoldt, L. Hoy, H. Weissbrodt and S. Häussler. Evaluation of the E test for the assessment of synergy of antibiotic combinations against multiresistant Pseudomonas aeruginosa isolates from cystic fibrosis patients. Eur J Clin Microbiol Infect Dis. 25:25-30. (2006) IF: 2.63
  63. Bredenbruch, F., M. Nimtz, V. Wray, M. Morr, R. Müller and S. Häussler. Biosynthetic pathway of Pseudomonas aeruginosa 4-hydroxy-2-alkylquinolines (HAQs). J. Bacteriol. 187:3630-5. (2005)   IF: 3.73   [Recommended by Faculty of 1000 Biology]
  64. von Götz, F., S. Häussler, D. Jordan, S. S. Saravanamuthu, D. Wehmhöner, A. Strussmann, J. Lauber, I. Attree, J. Buer, B. Tümmler and I. Steinmetz. Expression analysis of a highly adherent and cytotoxic small colony variant of Pseudomonas aeruginosa isolated from a lung of a patient with cystic fibrosis. J. Bacteriol. 186:3837-3847. (2004) IF: 3.73
  65. Balke, B., L. Hoy, H. Weissbrodt and S. Häussler. Comparison of the Micronaut Merlin automated broth microtiter system with the standard agar dilution method for antimicrobial susceptibility testing of mucoid and nonmucoid Pseudomonas aeruginosa isolates from cystic fibrosis patients. Eur. J. Clin. Microbiol. Infect. Dis. 23:765-771. (2004) IF: 2.63
  66. Wehmhöner, D., S. Häussler*, B. Tümmler, L. Jänsch, F. Bredenbruch, J. Wehland and I. Steinmetz. Inter- and intraclonal diversity of the Pseudomonas aeruginosa proteome manifests within the secretome. J. Bacteriol. 185:5807-5814. *korrespondierende Autorin. (2003) IF: 3.73
  67. Häussler, S., S. Ziesing, G. Rademacher, L. Hoy and H. Weissbrodt. Evaluation of the Merlin, Micronaut system for automated antimicrobial susceptibility testing of Pseudomonas aeruginosa and Burkholderia species isolated from cystic fibrosis patients. Eur. J. Clin. Microbiol. Infect. Dis. 22:496-500. (2003) IF: 2.63
  68. Häussler, S., I. Ziegler, A. Löttel, F. von Götz, M. Rohde, D. Wehmhöhner, S. Saravanamuthu, B. Tümmler and I. Steinmetz. Highly adherent small-colony variants of Pseudomonas aeruginosa in cystic fibrosis lung infection. J. Med. Microbiol. 52:295-301. (2003) IF: 2.38
  69. Häussler, S., M. Rohde, N. von Neuhoff, M. Nimtz and I. Steinmetz. Structural and functional cellular changes induced by Burkholderia pseudomallei rhamnolipid. Infect. Immun. 71:2970-2975. (2003) IF: 4.1
  70. Häussler, S., C. Lehmann, C. Breselge, M. Rohde, M. Classen, B. Tümmler, P. Vandamme, and I. Steinmetz. Fatal outcome of lung transplantation in cystic fibrosis patients due to small-colony variants of the Burkholderia cepacia complex. Eur. J. Clin. Microbiol. Infect. Dis. 22:249-253. (2003) IF: 2.63
  71. Breuer, K., S. Häussler, A. Kapp and T. Werfel. Staphylococcus aureus: colonizing features and influence of an antibacterial treatment in adults with atopic dermatitis. Br. J. Dermatol. 147:55-61. (2002) IF: 4.35
  72. Häussler S, Rohde M, Steinmetz I. Highly resistant Burkholderia pseudomallei small colony variants isolated in vitro and in experimental melioidosis. Med Microbiol Immunol.; 188:91-7. (1999) IF: 3.27
  73. Häussler S, Tümmler B, Weißbrodt H, Rohde M, Steinmetz I. Small-colony variants of Pseudomonas aeruginosa in cystic fibrosis. Clin Infect Dis. 29:621-5. (1999) IF: 8.19
  74. Hoppe I, Brenneke B, Rohde M, Kreft A, Häussler S, Reganzerowski A, Steinmetz I. Characterization of a murine model of melioidosis: comparison of different strains of mice. Infect Immun. 67 :2891-900. (1999) IF: 4.1
  75. Steinmetz I, Reganzerowski A, Brenneke B, Häussler S, Simpson A, White NJ. Rapid identification of Burkholderia pseudomallei by latex agglutination based on an exopolysaccharide-specific monoclonal antibody. J Clin Microbiol. 37:225-8. (1999) IF: 4.22
  76. Häussler S, Nimtz M, Domke T, Wray V, Steinmetz I. Purification and characterization of a cytotoxic exolipid of Burkholderia pseudomallei. Infect Immun. 66:1588-93. (1998) IF: 4.1
  77. Nimtz M, Wray V, Domke T, Brenneke B, Häussler S, Steinmetz I. Structure of an acidic exopolysaccharide of Burkholderia pseudomallei. Eur J Biochem. 250:608-16. (1997)
  78. Steinmetz I, Albrecht F, Häussler S, Brenneke B. 1994. Monoclonal IgA class-switch variants against bacterial surface antigens: molecular forms and transport into murine respiratory secretions. Eur J Immunol. 24:2855-62. (1994) IF: 4.94


Bachelor & Master
Are you interested in a bachelor or master thesis? We are looking forward to your request!

Audio Podcast

  • Wehrhafte BiofilmeEin Bakterium kommt selten allein; wenn es erst hinreichend viele sind, schließen sie sich zu Lebensgemeinschaften zusammen: Biofilmen. Und diese Biofilme verteidigen sich gegen Angreifer mit chemischen Waffen. Lassen Sie sich von dem Wissenschaftler Carsten Matz in die Welt der Biofilme mitnehmen.
PrintSend per emailShare